We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Research Ins]i[ghts: Cardiac Safety Symposium 2021
Webinar

Research Ins]i[ghts: Cardiac Safety Symposium 2021

Research Ins]i[ghts: Cardiac Safety Symposium 2021
Webinar

Research Ins]i[ghts: Cardiac Safety Symposium 2021

Yasunari Kanda, PhD
Yasunari Kanda, PhD
National Institute of Health Sciences, Japan
Michael K Pugsley, PhD, FBPhS, DSP
Michael K Pugsley, PhD, FBPhS, DSP
Director, Toxicology, Cytokinetics

Don't miss this 2-day interactive online event where the experts will be discussing current challenges in safety pharmacology and cardiac physiology, in silico modeling and best practices and evolvements of safety pharmacology methods.

See full agenda here

Register now to learn more about:

  • From iPSC banking to drug development and cardiac safety
  • Advanced cardiac contractility assessments
  • The use of stem cell cardiomyocyte models in predicting clinical cardiac endpoints
Advertisement